Omeros Corporation competitors

Omeros Corporation's competitors include Catalyst Pharmaceuticals, Akorn, ACADIA Pharmaceuticals and AdoRx Therapeutics
Add company...
Omeros Corporation
Omeros Corporation is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.
Akorn
Akorn is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products.
ACADIA Pharmaceuticals
ACADIA Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.
AdoRx Therapeutics
AdoRx Therapeutics is a company that pursues the discovery of new therapeutics for cancer based on modulation of the adenosine pathway.
Founding Date
Founding Date
1994
Founding Date
2002
Founding Date
1948
Founding Date
1993
Founding Date
N/A
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Seattle, US HQ
Locations
Coral Gables, US HQ
Locations
Lake Forest, US HQ
Gurugram, IN
Jersey, JE
Brooklyn, US
Queens, US
Houston, US
Ann Arbor, US
Locations
San Diego, US HQ
Locations
Edinburgh, GB HQ
Employees
Employees
154
Employees
18
Employees
2,261
Employees
42515% increase
Employees
N/A
Valuation ($)
Valuation ($)
1.2 b
Valuation ($)
323.2 m
Valuation ($)
1.7 b
Valuation ($)
2.5 b
Valuation ($)
N/A
Twitter followers
Twitter followers
80
Twitter followers
436
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$64.8m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$841m (FY, 2017)
Revenue (est.)
$124.9m (FY, 2017)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$1.1m (FY, 2017)
Cost of goods
N/A
Cost of goods
$407.9m (FY, 2017)
Cost of goods
$9.1m (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
$63.7m (FY, 2017)
Gross profit
N/A
Gross profit
$433.1m (FY, 2017)
Gross profit
$115.8m (FY, 2017)
Gross profit
N/A
Net income
Net income
($53.5m) (FY, 2017)
Net income
($18.4m) (FY, 2017)
Net income
($24.6m) (FY, 2017)
Net income
($289.4m) (FY, 2017)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 354.8m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 10m
For sources of this data, please see the company profileDownload Excel

View company profiles

Catalyst Pharmaceuticals
HQ
Coral Gables, US
Employees
18

Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.

View company
Akorn
HQ
Lake Forest, US
Employees
2,261

Akorn is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products.

View company
ACADIA Pharmaceuticals
HQ
San Diego, US
Employees
425↑ 15% increase

ACADIA Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.

View company
AdoRx Therapeutics
HQ
Edinburgh, GB

AdoRx Therapeutics is a company that pursues the discovery of new therapeutics for cancer based on modulation of the adenosine pathway.

View company